6 minutes
စစ်တပ်က ကြံခိုင်ရေးရုံးကို ဝင်စီးတယ်ဆိုတဲ့ သတင်းအတု တစ်ပုဒ် ထွက်ပေါ်နေပါတယ်။
စစ်တပ်က ကြံခိုင်ရေးရုံးကို ဝင်စီးတယ်ဆိုတဲ့ သတင်းအတု တစ်ပုဒ် ထွက်ပေါ်နေပါတယ်။
8 minutes
LOS ANGELES — Adam Miller volunteered with a Reform social justice movement as a teenager, lived in Israel as a young adult and was and became a leader of one of the country’s most successful synagogues. But Miller, a businessman who is running for mayor of Los Angeles, hasn’t said much about his Jewish background... The post He was president of his synagogue. Now he wants to be LA’s next mayor. appeared first on The Forward.
LOS ANGELES — Adam Miller volunteered with a Reform social justice movement as a teenager, lived in Israel as a young adult and was and became a leader of one of the country’s most successful synagogues. But Miller, a businessman who is running for mayor of Los Angeles, hasn’t said much about his Jewish background... The post He was president of his synagogue. Now he wants to be LA’s next mayor. appeared first on The Forward.
11 minutes
11 minutes
12 minutes

Cobreloa y Deportes Antofagasta se medirán en el “Clásico del Norte Grande”, por una nueva fecha del Campeonato de Ascenso 2026. El duelo está pactado para el próximo 3 de mayo en el estadio municipal Zorros del Desierto de Calama. El técnico minero, César Bravo, aseguró a En Cancha que “en un partido difícil, es […] Este artículo César Bravo sobre Antofagasta: “Es un partido difícil, es un clásico de la región” fue publicado originalmente en El Diario de Antofagasta.

Cobreloa y Deportes Antofagasta se medirán en el “Clásico del Norte Grande”, por una nueva fecha del Campeonato de Ascenso 2026. El duelo está pactado para el próximo 3 de mayo en el estadio municipal Zorros del Desierto de Calama. El técnico minero, César Bravo, aseguró a En Cancha que “en un partido difícil, es […] Este artículo César Bravo sobre Antofagasta: “Es un partido difícil, es un clásico de la región” fue publicado originalmente en El Diario de Antofagasta.
13 minutes
Gregg Garner, founder of Global Outreach Developments International, is facing another lawsuit alleging he induced church members to take out home equity lines of credit to fund an investment. Marsha Blackburn has called for a special session to redraw Tennessee's congressional districts to benefit Republicans, and early voting for the Davidson County primary is seeing increased participation. The post April 30: Anoter G.O.D. International Lawsuit; Davidson County Early Voting Update appeared first on Nashville Banner.
Gregg Garner, founder of Global Outreach Developments International, is facing another lawsuit alleging he induced church members to take out home equity lines of credit to fund an investment. Marsha Blackburn has called for a special session to redraw Tennessee's congressional districts to benefit Republicans, and early voting for the Davidson County primary is seeing increased participation. The post April 30: Anoter G.O.D. International Lawsuit; Davidson County Early Voting Update appeared first on Nashville Banner.
13 minutes
នៅថ្ងៃទី៣០ មេសា អាជ្ញាធរកូរ៉េខាងជើង តាមរយៈទីភ្នាក់ងារសារព័ត៌មានផ្លូវការ KCNA បានប្រាប់ឲ្យដឹងពីស្ថានភាពគ្រោះរាំងស្ងួតធ្ងន់ធ្ងរនៅក្នុងប្រទេស។ បើតាម KCNA គ្រោះរាំងស្ងួតដែលកូរ៉េខាងជើងទើបជួបប្រទះពេលនេះជាគ្រោះរាំងស្ងួតដែលប្រទេសឯកោមួយនេះមិនធ្លាប់ជួបពីឆ្នាំមុនៗមកទេ និងថា ប្រជាកសិករនៅតាមតំបន់ដែលកំពុងជួបគ្រោះរាំងស្ងួតកំពុងប្រឹងប្រែងការពារដំណាំ និងដាំដើមឈើបន្ថែមដើម្បីការពារ និងទប់ទល់ពីផលប៉ះពាល់លើដំណាំកសិកម្មរបស់ខ្លួន។
នៅថ្ងៃទី៣០ មេសា អាជ្ញាធរកូរ៉េខាងជើង តាមរយៈទីភ្នាក់ងារសារព័ត៌មានផ្លូវការ KCNA បានប្រាប់ឲ្យដឹងពីស្ថានភាពគ្រោះរាំងស្ងួតធ្ងន់ធ្ងរនៅក្នុងប្រទេស។ បើតាម KCNA គ្រោះរាំងស្ងួតដែលកូរ៉េខាងជើងទើបជួបប្រទះពេលនេះជាគ្រោះរាំងស្ងួតដែលប្រទេសឯកោមួយនេះមិនធ្លាប់ជួបពីឆ្នាំមុនៗមកទេ និងថា ប្រជាកសិករនៅតាមតំបន់ដែលកំពុងជួបគ្រោះរាំងស្ងួតកំពុងប្រឹងប្រែងការពារដំណាំ និងដាំដើមឈើបន្ថែមដើម្បីការពារ និងទប់ទល់ពីផលប៉ះពាល់លើដំណាំកសិកម្មរបស់ខ្លួន។
13 minutes
المرحلة الأولى تضم 10 مبانٍ تراث حديث شبكة بيئة ابوظبي، دبي، الإمارات العربية المتحدة، 30 أبريل 2026 أعلنت وزارة الثقافة عن إطلاق السجل الوطني للتراث المعماري الحديث، بالتزامن مع الاجتماع الأول للجنة الهوية الوطنية، برئاسة الشيخة مريم بنت محمد بن زايد آل نهيان وحضور أعضاء اللجنة، وذلك في خطوة نوعية تهدف إلى توثيق وحماية عناصر التراث المعماري الحديث في دولة الإمارات. وجاء إطلاق السجل كإحدى مبادرات استراتيجية الهوية الوطنية، والتي تم تطويرها بالشراكة بين وزارة الثقافة ومكتب المشاريع الوطنية في ديوان الرئاسة، وتتمحور رؤيتها حول انشاء سجل وطني متكامل للتراث الثقافي بشكل عام والتراث المعماري الحديث بشكل خاص لتعزيز هوية إماراتية راسخة يتبنّاها المجتمع سبيلًا لتحقيق الاستقرار والازدهار، وبما يعكس رؤية القيادة في جعل الهوية الإماراتية محورًا رئيسيًا في مختلف القطاعات، وترسيخ حضورها في السلوكيات والممارسات اليومية للمجتمع. كما يأتي السجل ضمن جهود تنفيذ السياسة الوطنية للحفاظ على التراث المعماري الحديث، التي اعتمدها مجلس الوزراء في عام 2024، وتستهدف صون المباني والمواقع التي تعود إلى فترة ما بعد ستينيات القرن الماضي، وتشمل مختلف أنماط البيئة العمرانية من مبانٍ ومجمعات ومرافق عامة ومنشآت ذات قيمة ثقافية وتاريخية. معالم حاضرة في ذكرة الوطن ويضم السجل الوطني للتراث المعماري الحديث في مرحلته الأولى عشرة مبانٍ مختارة تمثل محطات مفصلية في تطور العمارة الحديثة بدولة الإمارات، وهي: دار الاتحاد في دبي، بوصفها الموقع الذي شهد توقيع وثيقة الاتحاد عام 1971؛ وبرج راشد، الذي شكّل علامة فارقة في نشأة المشهد التجاري والاقتصادي الحديث في الإمارة منذ افتتاحه عام سنة 1979، وبرج الساعة في ديرة بدبي، كأحد أقدم الرموز الحضرية للمدينة، والمجلس الاستشاري الوطني في قصر الحصن بأبوظبي، المرتبط ببدايات العمل المؤسسي والتشريعي منذ عام 1968، والمجمع الثقافي في أبوظبي، باعتباره منصة رائدة للحراك الثقافي والفني منذ تأسيسه في عام 1982؛ والمعهد الإسلامي في جامعة الإمارات في مدينة العين، الذي يعكس تطور العمارة التعليمية والدينية الحديثة منذ عام 1976، ومدرسة خالد بن محمد في إمارة الشارقة، كنموذج بارز للعمارة التعليمية المرتبطة بتخطيط الأحياء السكنية، إضافة إلى مدرسة القاسمية في الشارقة، التي تمثل مرحلة متقدمة من تصميم المدارس الحكومية الحديثة منذ ثمانينيات القرن الماضي، ومركز دعم التربية الخاصة في الشارقة، بوصفه مثالًا على عمارة الخدمات التعليمية المتخصصة في مرحلة ما بعد الاتحاد، ومستشفى صقر في رأس الخيمة، الذي يجسد تطور البنية الصحية الحديثة ودوره المحوري في الذاكرة المجتمعية للدولة منذ عام 1981. وتستند عملية إدراج المباني في السجل إلى سبعة معايير رئيسية، من بينها ارتباط المبنى بالأحداث والشخصيات المؤثرة في تاريخ الدولة، وقيمته الجمالية والمعمارية، وقدرته على التعبير عن توجهات التخطيط الحضري في فترة معينة، إضافةً إلى الابتكار في التصميم، والأداء البيئي المستدام، ودوره في تعزيز الهوية الوطنية والذاكرة الجماعية. ويمنح إدراج المواقع في السجل عددًا من المحفزات، من أبرزها الاعتراف الوطني الرسمي، وتعزيز الحماية التشريعية، والأولوية في برامج الدعم والتمويل، إضافةً إلى دعم جهود التوثيق والبحث، وتعزيز السياحة الثقافية والمعمارية على المستويين المحلي والدولي. لجنة الهوية الوطنية.. حوكمة ملف الهوية الجدير بالذكر أنه تم تأسيس لجنة الهوية الوطنية في أعقاب إطلاق استراتيجية الهوية الوطنية، وبما يعكس التزام دولة الإمارات برؤية قيادتها في بناء إنسانٍ واثقٍ بجذوره ومحافظٍ على أصالته، حيث جاءت الاستراتيجية لتكون إطارًا وطنيًا جامعًا ينسّق الجهود بين مختلف الجهات، ويحوّل الهوية من مفهومٍ ثقافي إلى ممارسةٍ مجتمعيةٍ حيّة تترسّخ في الحياة اليومية”. وتهدف اللجنة إلى حوكمة ملف الهوية الوطنية وتمكين الجهات ذات العلاقة وتنسيق جهودها ومواءمة خططها ضمن إطار وطني موحّد، بما يضمن تكامل الأدوار وتوحيد التوجهات المستقبلية في تعزيز الهوية الإماراتية على المستويين المؤسسي والمجتمعي. وتضم اللجنة في عضويتها كل من الشيخة حصة بنت محمد بن حمد بن طحنون آل نهيان، مستشاراً لرئيس اللجنة، ومعالي الشيخ سالم بن خالد القاسمي، وزير الثقافة، ومعالي عبدالله بن محمد بن بطي آل حامد، رئيس الهيئة الوطنية للإعلام، ومعالي راشد سعيد العامري، مستشار في مكتب رئيس الدولة للشؤون الإستراتيجية بديوان الرئاسة، ومعالي عبدالله بن طوق المري، وزير الاقتصاد والسياحة، ومعالي الدكتور سلطان بن سيف النيادي، وزير دولة لشؤون الشباب، ومعالي سميرة مرشد الرميثي، أمين عام الهيئة الرئاسية للمراسم والسرد الإستراتيجي، ومعالي هاجر أحمد الذهلي، الأمين العام لمجلس التعليم والتنمية البشرية والمجتمع، ومعالي الدكتور عمر حبتور الدرعي، رئيس الهيئة العامة للشؤون الإسلامية والأوقاف والزكاة، وسعادة حمد عبدالله الزعابي، المدير العام لمكتب المشاريع الوطنية بديوان الرئاسة. ظهرت المقالة وزارة الثقافة تعلن إطلاق السجل الوطني للتراث المعماري الحديث أولاً على بيئة أبوظبي.
المرحلة الأولى تضم 10 مبانٍ تراث حديث شبكة بيئة ابوظبي، دبي، الإمارات العربية المتحدة، 30 أبريل 2026 أعلنت وزارة الثقافة عن إطلاق السجل الوطني للتراث المعماري الحديث، بالتزامن مع الاجتماع الأول للجنة الهوية الوطنية، برئاسة الشيخة مريم بنت محمد بن زايد آل نهيان وحضور أعضاء اللجنة، وذلك في خطوة نوعية تهدف إلى توثيق وحماية عناصر التراث المعماري الحديث في دولة الإمارات. وجاء إطلاق السجل كإحدى مبادرات استراتيجية الهوية الوطنية، والتي تم تطويرها بالشراكة بين وزارة الثقافة ومكتب المشاريع الوطنية في ديوان الرئاسة، وتتمحور رؤيتها حول انشاء سجل وطني متكامل للتراث الثقافي بشكل عام والتراث المعماري الحديث بشكل خاص لتعزيز هوية إماراتية راسخة يتبنّاها المجتمع سبيلًا لتحقيق الاستقرار والازدهار، وبما يعكس رؤية القيادة في جعل الهوية الإماراتية محورًا رئيسيًا في مختلف القطاعات، وترسيخ حضورها في السلوكيات والممارسات اليومية للمجتمع. كما يأتي السجل ضمن جهود تنفيذ السياسة الوطنية للحفاظ على التراث المعماري الحديث، التي اعتمدها مجلس الوزراء في عام 2024، وتستهدف صون المباني والمواقع التي تعود إلى فترة ما بعد ستينيات القرن الماضي، وتشمل مختلف أنماط البيئة العمرانية من مبانٍ ومجمعات ومرافق عامة ومنشآت ذات قيمة ثقافية وتاريخية. معالم حاضرة في ذكرة الوطن ويضم السجل الوطني للتراث المعماري الحديث في مرحلته الأولى عشرة مبانٍ مختارة تمثل محطات مفصلية في تطور العمارة الحديثة بدولة الإمارات، وهي: دار الاتحاد في دبي، بوصفها الموقع الذي شهد توقيع وثيقة الاتحاد عام 1971؛ وبرج راشد، الذي شكّل علامة فارقة في نشأة المشهد التجاري والاقتصادي الحديث في الإمارة منذ افتتاحه عام سنة 1979، وبرج الساعة في ديرة بدبي، كأحد أقدم الرموز الحضرية للمدينة، والمجلس الاستشاري الوطني في قصر الحصن بأبوظبي، المرتبط ببدايات العمل المؤسسي والتشريعي منذ عام 1968، والمجمع الثقافي في أبوظبي، باعتباره منصة رائدة للحراك الثقافي والفني منذ تأسيسه في عام 1982؛ والمعهد الإسلامي في جامعة الإمارات في مدينة العين، الذي يعكس تطور العمارة التعليمية والدينية الحديثة منذ عام 1976، ومدرسة خالد بن محمد في إمارة الشارقة، كنموذج بارز للعمارة التعليمية المرتبطة بتخطيط الأحياء السكنية، إضافة إلى مدرسة القاسمية في الشارقة، التي تمثل مرحلة متقدمة من تصميم المدارس الحكومية الحديثة منذ ثمانينيات القرن الماضي، ومركز دعم التربية الخاصة في الشارقة، بوصفه مثالًا على عمارة الخدمات التعليمية المتخصصة في مرحلة ما بعد الاتحاد، ومستشفى صقر في رأس الخيمة، الذي يجسد تطور البنية الصحية الحديثة ودوره المحوري في الذاكرة المجتمعية للدولة منذ عام 1981. وتستند عملية إدراج المباني في السجل إلى سبعة معايير رئيسية، من بينها ارتباط المبنى بالأحداث والشخصيات المؤثرة في تاريخ الدولة، وقيمته الجمالية والمعمارية، وقدرته على التعبير عن توجهات التخطيط الحضري في فترة معينة، إضافةً إلى الابتكار في التصميم، والأداء البيئي المستدام، ودوره في تعزيز الهوية الوطنية والذاكرة الجماعية. ويمنح إدراج المواقع في السجل عددًا من المحفزات، من أبرزها الاعتراف الوطني الرسمي، وتعزيز الحماية التشريعية، والأولوية في برامج الدعم والتمويل، إضافةً إلى دعم جهود التوثيق والبحث، وتعزيز السياحة الثقافية والمعمارية على المستويين المحلي والدولي. لجنة الهوية الوطنية.. حوكمة ملف الهوية الجدير بالذكر أنه تم تأسيس لجنة الهوية الوطنية في أعقاب إطلاق استراتيجية الهوية الوطنية، وبما يعكس التزام دولة الإمارات برؤية قيادتها في بناء إنسانٍ واثقٍ بجذوره ومحافظٍ على أصالته، حيث جاءت الاستراتيجية لتكون إطارًا وطنيًا جامعًا ينسّق الجهود بين مختلف الجهات، ويحوّل الهوية من مفهومٍ ثقافي إلى ممارسةٍ مجتمعيةٍ حيّة تترسّخ في الحياة اليومية”. وتهدف اللجنة إلى حوكمة ملف الهوية الوطنية وتمكين الجهات ذات العلاقة وتنسيق جهودها ومواءمة خططها ضمن إطار وطني موحّد، بما يضمن تكامل الأدوار وتوحيد التوجهات المستقبلية في تعزيز الهوية الإماراتية على المستويين المؤسسي والمجتمعي. وتضم اللجنة في عضويتها كل من الشيخة حصة بنت محمد بن حمد بن طحنون آل نهيان، مستشاراً لرئيس اللجنة، ومعالي الشيخ سالم بن خالد القاسمي، وزير الثقافة، ومعالي عبدالله بن محمد بن بطي آل حامد، رئيس الهيئة الوطنية للإعلام، ومعالي راشد سعيد العامري، مستشار في مكتب رئيس الدولة للشؤون الإستراتيجية بديوان الرئاسة، ومعالي عبدالله بن طوق المري، وزير الاقتصاد والسياحة، ومعالي الدكتور سلطان بن سيف النيادي، وزير دولة لشؤون الشباب، ومعالي سميرة مرشد الرميثي، أمين عام الهيئة الرئاسية للمراسم والسرد الإستراتيجي، ومعالي هاجر أحمد الذهلي، الأمين العام لمجلس التعليم والتنمية البشرية والمجتمع، ومعالي الدكتور عمر حبتور الدرعي، رئيس الهيئة العامة للشؤون الإسلامية والأوقاف والزكاة، وسعادة حمد عبدالله الزعابي، المدير العام لمكتب المشاريع الوطنية بديوان الرئاسة. ظهرت المقالة وزارة الثقافة تعلن إطلاق السجل الوطني للتراث المعماري الحديث أولاً على بيئة أبوظبي.
16 minutes

Forumi për Ndryshime në Arsim ka raportuar për një avancim të kundërligjshëm në Universitetin e Tetovës, bazuar në raprotin e Inspektoratit Shtetëror të Arsimit, ata raportojnë se Arbresha Bexheti Ferati, e angazhuar në Fakultetin e Mjekësisë dhe njëkohësisht bashkëshorte e kryetarit të Senatit të Universitetit të Tetovës ka arritur që të avancohet në tituj akademik […]

Forumi për Ndryshime në Arsim ka raportuar për një avancim të kundërligjshëm në Universitetin e Tetovës, bazuar në raprotin e Inspektoratit Shtetëror të Arsimit, ata raportojnë se Arbresha Bexheti Ferati, e angazhuar në Fakultetin e Mjekësisë dhe njëkohësisht bashkëshorte e kryetarit të Senatit të Universitetit të Tetovës ka arritur që të avancohet në tituj akademik […]
16 minutes
Martesha Johnson Moore has been leading the Metro Public Defender's Office since 2018 and is running unopposed for reelection this year. She continues to advocate for increased investment in the criminal justice system to provide better representation for those who cannot afford private attorneys. The post Metro Public Defender Martesha Johnson Moore on Caseloads, the Cash Bail System and More appeared first on Nashville Banner.
Martesha Johnson Moore has been leading the Metro Public Defender's Office since 2018 and is running unopposed for reelection this year. She continues to advocate for increased investment in the criminal justice system to provide better representation for those who cannot afford private attorneys. The post Metro Public Defender Martesha Johnson Moore on Caseloads, the Cash Bail System and More appeared first on Nashville Banner.
16 minutes

Cobreloa y Deportes Antofagasta se medirán en el “Clásico del Norte Grande”, por una nueva fecha del Campeonato de Ascenso 2026. El dueño está pactado para el próximo 3 de mayo en el estadio municipal Zorros del Desierto de Calama. El técnico albiceleste, Luis Marcoleta, expresó a Liga Sports que “claro es un clásico, todos […] Este artículo Luis Marcoleta sobre Cobreloa: “Es un clásico, ojalá sea un partido atractivo” fue publicado originalmente en El Diario de Antofagasta.

Cobreloa y Deportes Antofagasta se medirán en el “Clásico del Norte Grande”, por una nueva fecha del Campeonato de Ascenso 2026. El dueño está pactado para el próximo 3 de mayo en el estadio municipal Zorros del Desierto de Calama. El técnico albiceleste, Luis Marcoleta, expresó a Liga Sports que “claro es un clásico, todos […] Este artículo Luis Marcoleta sobre Cobreloa: “Es un clásico, ojalá sea un partido atractivo” fue publicado originalmente en El Diario de Antofagasta.
17 minutes
Nearly half of all evictions filed in Oklahoma County during the first quarter of this year were dismissed, and, of those dismissed, 18% were dropped before the first court hearing, according to data from the Mental Health Association Oklahoma. This indicates that eviction filings were being used as a form of rent collection, according to the association. The post Oklahoma’s Eviction Process Is Being Used as a Form of Rent Collection, Data Shows appeared first on Oklahoma Watch.
Nearly half of all evictions filed in Oklahoma County during the first quarter of this year were dismissed, and, of those dismissed, 18% were dropped before the first court hearing, according to data from the Mental Health Association Oklahoma. This indicates that eviction filings were being used as a form of rent collection, according to the association. The post Oklahoma’s Eviction Process Is Being Used as a Form of Rent Collection, Data Shows appeared first on Oklahoma Watch.
17 minutes
Суд в Оренбургской области в течение апреля рассмотрел пять жалоб осужденного на пожизненный срок экс-сенатора от Карачаево-Черкесии Рауфа Арашукова. Он жаловался на бытовые сложности в колонии – все обращения были отклонены. Ранее Арашукову не удалось добиться ни перевода из "Черного дельфина", ни отправки на войну в Украину. Все пять исков опубликованы в картотеке дел Соль-Илецкого райсуда. Последнее решение вынесли 30 апреля. В этой жалобе Арашуков требовал возместить ему моральный вред...
Суд в Оренбургской области в течение апреля рассмотрел пять жалоб осужденного на пожизненный срок экс-сенатора от Карачаево-Черкесии Рауфа Арашукова. Он жаловался на бытовые сложности в колонии – все обращения были отклонены. Ранее Арашукову не удалось добиться ни перевода из "Черного дельфина", ни отправки на войну в Украину. Все пять исков опубликованы в картотеке дел Соль-Илецкого райсуда. Последнее решение вынесли 30 апреля. В этой жалобе Арашуков требовал возместить ему моральный вред...
17 minutes

Lienne Sethna and Adam Heathcote, scientists with the Science Museum of Minnesota, were paddling toward a portage in the Boundary Waters Canoe Area Wilderness on a mild, sunny August afternoon in 2024 when their canoe sliced through a glistening green scum floating on the water. The scientists, who are part of the St. Croix Watershed […]

Lienne Sethna and Adam Heathcote, scientists with the Science Museum of Minnesota, were paddling toward a portage in the Boundary Waters Canoe Area Wilderness on a mild, sunny August afternoon in 2024 when their canoe sliced through a glistening green scum floating on the water. The scientists, who are part of the St. Croix Watershed […]
18 minutes
The world’s first conference on phasing out fossil fuels has ended in Colombia with delegates from 56 countries declaring that the global debate has shifted from whether to stop using oil, gas and coal to how to do it. Debt and financing remain major obstacles.
The world’s first conference on phasing out fossil fuels has ended in Colombia with delegates from 56 countries declaring that the global debate has shifted from whether to stop using oil, gas and coal to how to do it. Debt and financing remain major obstacles.
18 minutes

The Michigan Supreme Court adopted a rule on Wednesday to prohibit civil arrests, including the civil immigration warrants commonly used by ICE, which are administrative warrants, not judicial warrants. Specifically, the new rule, which will go into effect on May 1, states that “Parties, attorneys, and subpoenaed witnesses are not subject to civil arrest while […]

18 minutes
The Michigan Supreme Court adopted a rule on Wednesday to prohibit civil arrests, including the civil immigration warrants commonly used by ICE, which are administrative warrants, not judicial warrants. Specifically, the new rule, which will go into effect on May 1, states that “Parties, attorneys, and subpoenaed witnesses are not subject to civil arrest while […]
18 minutes
Entrevista com programador revela bastidores e desafios da curadoria internacional; Festival des 3 Continents e Biarritz recebem inscrições O post Giro Cine Ninja Europa: Festivais fortalecem circulação do cinema latino-americano apareceu primeiro em Mídia NINJA.
Entrevista com programador revela bastidores e desafios da curadoria internacional; Festival des 3 Continents e Biarritz recebem inscrições O post Giro Cine Ninja Europa: Festivais fortalecem circulação do cinema latino-americano apareceu primeiro em Mídia NINJA.
18 minutes
Public health, explained: Sign up to receive Healthbeat’s Global Checkup in your inbox a day early.Hello from Nairobi.This week we’re following some remarkable medical advances: a potential breakthrough in a long-neglected disease, and new treatments and tests for the world’s deadliest parasite. We also have an update to last week’s story on American HIV aid, and, at the end, a sci-fi-meets-Ken-Kesey story that combines psychedelic toad-licking, ayahuasca, tobacco, and genetically engineered bacteria. My name is William Herkewitz, and I’m a journalist based in Nairobi, Kenya. This is the Global Health Checkup, where I highlight some of the week’s most important stories on outbreaks, medicine, science, and survival from around the world.With that, as we say in Swahili: karibu katika habari — welcome to the news.‘Astonishing discovery’ for a little-studied, disfiguring disease Scientists believe they may have finally found the root cause of noma, a disfiguring illness in the sad bucket of “neglected tropical diseases,” The Guardian reports.Disease breakdown: Noma is a rare but rapidly progressing disease of the mouth and face. It’s largely a children’s disease of poverty, with no single, proven cause, but an estimated 30,000 to 140,000 cases a year. Most cases are in children under 6 years old, across a belt of African countries from Mauritania to Nigeria to Ethiopia. Untreated, it kills 90% of those affected, and even with treatment the heartbreaking disease often leaves lifelong facial deformities and scars.The new discovery was a bit serendipitous. Researchers at the Liverpool School of Tropical Medicine set out to map the bacteria living in the mouths of 19 children with noma across Nigeria. In the process, they uncovered a previously unknown species of bacteria, now called Treponema A. The obvious question followed: Could this be the cause of the illness? To make sure it wasn’t a fluke, the researchers went back to “reanalyze older samples from other noma patients” and found the same bacteria there, too.As The Guardian reports, this “astonishing discovery” doesn’t necessarily prove that the new bacteria cause the disease, but it certainly gives scientists something concrete to chase. As one researcher put it, “we don’t know if [Treponema A] can colonize a noma wound, because of the architecture and the environment, or if it causes the noma wound.” Still, it’s an incredible starting point.I reached out to Stuart Ainsworth, an infection biology and microbiome expert at the University of Liverpool, and part of the team behind the discovery. We discussed what this finding means and what it shows about the value of researching neglected diseases. I started by asking Ainsworth how a disease this severe could still have such basic unanswered questions, and how a lead like this could have gone unnoticed for so long. Ainsworth was frank: “There has hardly been any research on noma at all,” he said. He pointed to a 2021 review of the history of noma research, which found that there have only been 147 studies done on the disease since the year 1850. “In comparison, there were around 650 papers on rabies in 2021 alone,” he told me.The core issue is that noma, Ainsworth says, “is the quintessential neglected disease. It only affects the very poorest in society and typically occurs in remote rural regions.” And because those who aren’t killed by the disease are often “left debilitated and scarred and generally hidden from society,” he said, “there is little impetus globally to invest in research.” It’s a brutal dynamic, and one that cuts to the core purpose of medical research. “The goal with all diseases is to eradicate them, or at least control them to the point where they are no longer an issue.” And yet, “all of these things are impossible if you do not have at least a very basic understanding of what is the cause of the disease,” he said.But that bleak starting point is also what gives this kind of scientific work such an incredible upside. “We know so very little” about noma that even “simple targeted research could potentially have a huge impact,” he said. Looking forward, Ainsworth says further research could help move beyond the current treatment for noma, which is a shotgun approach of broad antibiotics, and that “we hope that these types of studies will eventually enable us to develop the targeted prevention, diagnostic, and treatment options to eradicate or prevent noma.”A stalling fight against HIV, part 2Last week we covered new data that showed U.S.-funded HIV treatment holding steady on paper, but testing, prevention, and case detection dropped sharply, raising fears about a surge in new infections.Well, there are a few follow-on stories that are worth your time. (First, we’re owed a correction. I flagged the State Department’s claim that “20.6 million people” are on HIV treatment, but it appears that the official figures don’t actually match the underlying data, which puts the number closer to 20.3 million.)Second, the person in charge of the science behind that data just left. Mike Reid, the HIV program’s chief science officer, stepped down. He blames a system where American HIV aid is being “entangled with access to critical minerals or geopolitical positioning,” to the detriment of the work, Reuters reports.Reid posted a full essay on Substack upon his departure, and there are a few sections worth pulling out to understand why he walked.Reid starts with the core shift:“When life-saving health assistance, often beyond the immediate capacity of partner countries, is conditioned on unrelated commercial or strategic objectives, something essential is lost … That is not a marginal adjustment. It is a different model. And I do not believe that model is consistent with the purpose of global health. I do not believe it serves patients, or countries, or ultimately even the long-term interests of the United States.”He follows with a strikingly blunt assessment, which directly contradicts the State Department’s framing, and echoes what many HIV experts have been warning about.“We have asked partner governments to take on substantial new responsibilities despite constrained fiscal space, high levels of sovereign debt, and growing demographic pressures, all while programs themselves have been weakened by recent U.S. funding cuts. In places like Zambia, which I care about deeply, the consequences of stepping away too abruptly could be devastating, and avoidable. I have to take that possibility seriously.”Ultimately, Reid casts his resignation as a break with the core idea of the field itself. “I’ve believed that global health — at its best — is a form of solidarity. Not charity. Not strategy.” And now, that very belief “is why I am resigning my post as chief science officer at PEPFAR in the U.S. State Department.”A malaria drug for newborns For the first time, there’s a malaria drug for newborns, Deutsche Welle reports. Disease breakdown: Malaria is the world’s deadliest parasitic disease. The parasite spreads almost entirely through mosquito bites, then moves into the blood and causes cycles of fever, chills, and severe anemia. Young children are hit hardest because they have little natural immunity. The disease is preventable and treatable. Vaccines exist, but they reduce risk rather than eliminate the threat altogether. The treatment was just approved by the World Health Organization for “babies weighing less than 5 kilograms (11 pounds).” Its development closes what was previously a “medical care gap for 30 million babies born each year in malaria-endemic areas" across Africa, which is by far the hardest-hit continent. Technically, it’s a new formulation of two existing treatments: artemether and lumefantrine, which were developed thanks to a secret Chinese military project in the ’60s and ’70s to aid the North during the Vietnam war. (Really!)Together, the drugs hijack the malaria parasite’s eating process, so that the blood molecules (hemoglobin) that should feed it actually end up destroying it.You may be asking: If this is the first ever treatment, how have sick infants been treated until now? Well, routinely “infants have been treated with drugs developed for older children,” an imperfect workaround, as these drugs can “expose newborns to risks of dosing errors and toxicity.”My takeaway: It’s encouraging that medical science keeps providing tools to fight and treat this disease. Earlier this month, the WHO also approved three new rapid tests for “malaria parasites [that] have evolved to become harder to detect,” as they stopped producing the molecule that older tests relied on. Very timely! In some countries in the Horn of Africa (like Ethiopia, Djibouti, and Somalia), those tests started missing “up to 80% of cases.” India’s largest pharma dealIndia’s largest drugmaker, Sun Pharmaceutical Industries, has just made the country’s “largest pharma deal,” Reuters reports. The company has agreed to buy the U.S.-based Organon & Co. It’s an $11.75 billion all-cash deal, the most expensive overseas acquisition ever by an Indian company. Why does this matter?Let me pepper in a bit of context: As we’ve written before, India, the “pharmacy of the world,” is where a fifth of all generic drugs and well over half of all vaccines are manufactured. And Sun Pharma is India’s biggest drugmaker by revenue, churning out over a thousand separate medicines and drug ingredients. A true generics giant, those drugs include everything from diabetes treatments and psychiatric drugs to cancer therapies and dermatology medicines. Meanwhile, Organon (which started as an insulin producer over 100 years ago) makes specialty medicines: contraceptives and drugs for pregnancy and menopause, along with a variety of other hormone-based therapies. Although it’s a minnow in the American market, it produces “70 women’s health and general medicines sold across about 140 countries.”If you scan through the link you’ll see that the Reuters story is a business one, full of debt figures and deal details. What’s more interesting is what this deal reflects about India’s pharma sector more broadly. The big takeaway is this: India’s pharmaceutical sector is enormous, and only growing. Many projections have the entire sector doubling in value from 2025 to just 2030. Much of that growth is expected to come from a shift out of cheap generics into specialty medicines, and so this is exactly the kind of deal that will help make that shift real.Whatever you do, don’t smoke thisLet’s end on a fairly wild story from New Scientist: A research group based at the Weizmann Institute of Science in Israel has "engineered tobacco plants to produce five powerful psychedelic compounds,” all in a single plant. As the authors argue, this could offer a more sustainable way to produce psychedelic drugs, “which are increasingly in demand for research and medical uses.”What I find particularly interesting about this story isn’t just the tie dye-inducing tobacco plant. It’s the fascinating technique the scientists used, which lands just shy of permanent gene-editing. Here’s the explainer from the story:“[The scientists] modified Nicotiana benthamiana plants using a technique called agroinfiltration, which involves using a bacterium to introduce genes from other organisms into a plant. The modified plant then makes the proteins encoded by those genes, but the DNA isn’t incorporated into the plant’s genome, so the effect is short-lived.”Ultimately, those bacteria induced the tobacco plants to produce psilocin and psilocybin, two compounds found in “magic mushrooms”; DMT, which is found in the psychoactive drink ayahuasca; and bufotenin and 5-methoxy-DMT, which are secreted by Colorado river toads. The researchers argue that their method is a much easier way to produce these molecules for medical testing than, say, raising cages full of toads. And it’s doing it across biological kingdoms, creating compounds from fungi, plants, and animals in a single organism.The takeaway: As the article outlines, “the idea of growing drugs through pharmaceutical farming, or ‘pharming,’ certainly isn’t new.” As far back as 2002, we’ve had corn engineered to produce trypsin, a digestive enzyme. But doing it temporarily, without forever altering the plant’s genome, limits the risk of these traits escaping or persisting in the wild.And heck, it makes the infamous “Simpsons” “tomacco” plant look as everyday as a steamed ham. Until next week,WilliamWilliam Herkewitz is a reporter covering global public health for Healthbeat. He is based in Nairobi. Contact William at wherkewitz@healthbeat.org.
Public health, explained: Sign up to receive Healthbeat’s Global Checkup in your inbox a day early.Hello from Nairobi.This week we’re following some remarkable medical advances: a potential breakthrough in a long-neglected disease, and new treatments and tests for the world’s deadliest parasite. We also have an update to last week’s story on American HIV aid, and, at the end, a sci-fi-meets-Ken-Kesey story that combines psychedelic toad-licking, ayahuasca, tobacco, and genetically engineered bacteria. My name is William Herkewitz, and I’m a journalist based in Nairobi, Kenya. This is the Global Health Checkup, where I highlight some of the week’s most important stories on outbreaks, medicine, science, and survival from around the world.With that, as we say in Swahili: karibu katika habari — welcome to the news.‘Astonishing discovery’ for a little-studied, disfiguring disease Scientists believe they may have finally found the root cause of noma, a disfiguring illness in the sad bucket of “neglected tropical diseases,” The Guardian reports.Disease breakdown: Noma is a rare but rapidly progressing disease of the mouth and face. It’s largely a children’s disease of poverty, with no single, proven cause, but an estimated 30,000 to 140,000 cases a year. Most cases are in children under 6 years old, across a belt of African countries from Mauritania to Nigeria to Ethiopia. Untreated, it kills 90% of those affected, and even with treatment the heartbreaking disease often leaves lifelong facial deformities and scars.The new discovery was a bit serendipitous. Researchers at the Liverpool School of Tropical Medicine set out to map the bacteria living in the mouths of 19 children with noma across Nigeria. In the process, they uncovered a previously unknown species of bacteria, now called Treponema A. The obvious question followed: Could this be the cause of the illness? To make sure it wasn’t a fluke, the researchers went back to “reanalyze older samples from other noma patients” and found the same bacteria there, too.As The Guardian reports, this “astonishing discovery” doesn’t necessarily prove that the new bacteria cause the disease, but it certainly gives scientists something concrete to chase. As one researcher put it, “we don’t know if [Treponema A] can colonize a noma wound, because of the architecture and the environment, or if it causes the noma wound.” Still, it’s an incredible starting point.I reached out to Stuart Ainsworth, an infection biology and microbiome expert at the University of Liverpool, and part of the team behind the discovery. We discussed what this finding means and what it shows about the value of researching neglected diseases. I started by asking Ainsworth how a disease this severe could still have such basic unanswered questions, and how a lead like this could have gone unnoticed for so long. Ainsworth was frank: “There has hardly been any research on noma at all,” he said. He pointed to a 2021 review of the history of noma research, which found that there have only been 147 studies done on the disease since the year 1850. “In comparison, there were around 650 papers on rabies in 2021 alone,” he told me.The core issue is that noma, Ainsworth says, “is the quintessential neglected disease. It only affects the very poorest in society and typically occurs in remote rural regions.” And because those who aren’t killed by the disease are often “left debilitated and scarred and generally hidden from society,” he said, “there is little impetus globally to invest in research.” It’s a brutal dynamic, and one that cuts to the core purpose of medical research. “The goal with all diseases is to eradicate them, or at least control them to the point where they are no longer an issue.” And yet, “all of these things are impossible if you do not have at least a very basic understanding of what is the cause of the disease,” he said.But that bleak starting point is also what gives this kind of scientific work such an incredible upside. “We know so very little” about noma that even “simple targeted research could potentially have a huge impact,” he said. Looking forward, Ainsworth says further research could help move beyond the current treatment for noma, which is a shotgun approach of broad antibiotics, and that “we hope that these types of studies will eventually enable us to develop the targeted prevention, diagnostic, and treatment options to eradicate or prevent noma.”A stalling fight against HIV, part 2Last week we covered new data that showed U.S.-funded HIV treatment holding steady on paper, but testing, prevention, and case detection dropped sharply, raising fears about a surge in new infections.Well, there are a few follow-on stories that are worth your time. (First, we’re owed a correction. I flagged the State Department’s claim that “20.6 million people” are on HIV treatment, but it appears that the official figures don’t actually match the underlying data, which puts the number closer to 20.3 million.)Second, the person in charge of the science behind that data just left. Mike Reid, the HIV program’s chief science officer, stepped down. He blames a system where American HIV aid is being “entangled with access to critical minerals or geopolitical positioning,” to the detriment of the work, Reuters reports.Reid posted a full essay on Substack upon his departure, and there are a few sections worth pulling out to understand why he walked.Reid starts with the core shift:“When life-saving health assistance, often beyond the immediate capacity of partner countries, is conditioned on unrelated commercial or strategic objectives, something essential is lost … That is not a marginal adjustment. It is a different model. And I do not believe that model is consistent with the purpose of global health. I do not believe it serves patients, or countries, or ultimately even the long-term interests of the United States.”He follows with a strikingly blunt assessment, which directly contradicts the State Department’s framing, and echoes what many HIV experts have been warning about.“We have asked partner governments to take on substantial new responsibilities despite constrained fiscal space, high levels of sovereign debt, and growing demographic pressures, all while programs themselves have been weakened by recent U.S. funding cuts. In places like Zambia, which I care about deeply, the consequences of stepping away too abruptly could be devastating, and avoidable. I have to take that possibility seriously.”Ultimately, Reid casts his resignation as a break with the core idea of the field itself. “I’ve believed that global health — at its best — is a form of solidarity. Not charity. Not strategy.” And now, that very belief “is why I am resigning my post as chief science officer at PEPFAR in the U.S. State Department.”A malaria drug for newborns For the first time, there’s a malaria drug for newborns, Deutsche Welle reports. Disease breakdown: Malaria is the world’s deadliest parasitic disease. The parasite spreads almost entirely through mosquito bites, then moves into the blood and causes cycles of fever, chills, and severe anemia. Young children are hit hardest because they have little natural immunity. The disease is preventable and treatable. Vaccines exist, but they reduce risk rather than eliminate the threat altogether. The treatment was just approved by the World Health Organization for “babies weighing less than 5 kilograms (11 pounds).” Its development closes what was previously a “medical care gap for 30 million babies born each year in malaria-endemic areas" across Africa, which is by far the hardest-hit continent. Technically, it’s a new formulation of two existing treatments: artemether and lumefantrine, which were developed thanks to a secret Chinese military project in the ’60s and ’70s to aid the North during the Vietnam war. (Really!)Together, the drugs hijack the malaria parasite’s eating process, so that the blood molecules (hemoglobin) that should feed it actually end up destroying it.You may be asking: If this is the first ever treatment, how have sick infants been treated until now? Well, routinely “infants have been treated with drugs developed for older children,” an imperfect workaround, as these drugs can “expose newborns to risks of dosing errors and toxicity.”My takeaway: It’s encouraging that medical science keeps providing tools to fight and treat this disease. Earlier this month, the WHO also approved three new rapid tests for “malaria parasites [that] have evolved to become harder to detect,” as they stopped producing the molecule that older tests relied on. Very timely! In some countries in the Horn of Africa (like Ethiopia, Djibouti, and Somalia), those tests started missing “up to 80% of cases.” India’s largest pharma dealIndia’s largest drugmaker, Sun Pharmaceutical Industries, has just made the country’s “largest pharma deal,” Reuters reports. The company has agreed to buy the U.S.-based Organon & Co. It’s an $11.75 billion all-cash deal, the most expensive overseas acquisition ever by an Indian company. Why does this matter?Let me pepper in a bit of context: As we’ve written before, India, the “pharmacy of the world,” is where a fifth of all generic drugs and well over half of all vaccines are manufactured. And Sun Pharma is India’s biggest drugmaker by revenue, churning out over a thousand separate medicines and drug ingredients. A true generics giant, those drugs include everything from diabetes treatments and psychiatric drugs to cancer therapies and dermatology medicines. Meanwhile, Organon (which started as an insulin producer over 100 years ago) makes specialty medicines: contraceptives and drugs for pregnancy and menopause, along with a variety of other hormone-based therapies. Although it’s a minnow in the American market, it produces “70 women’s health and general medicines sold across about 140 countries.”If you scan through the link you’ll see that the Reuters story is a business one, full of debt figures and deal details. What’s more interesting is what this deal reflects about India’s pharma sector more broadly. The big takeaway is this: India’s pharmaceutical sector is enormous, and only growing. Many projections have the entire sector doubling in value from 2025 to just 2030. Much of that growth is expected to come from a shift out of cheap generics into specialty medicines, and so this is exactly the kind of deal that will help make that shift real.Whatever you do, don’t smoke thisLet’s end on a fairly wild story from New Scientist: A research group based at the Weizmann Institute of Science in Israel has "engineered tobacco plants to produce five powerful psychedelic compounds,” all in a single plant. As the authors argue, this could offer a more sustainable way to produce psychedelic drugs, “which are increasingly in demand for research and medical uses.”What I find particularly interesting about this story isn’t just the tie dye-inducing tobacco plant. It’s the fascinating technique the scientists used, which lands just shy of permanent gene-editing. Here’s the explainer from the story:“[The scientists] modified Nicotiana benthamiana plants using a technique called agroinfiltration, which involves using a bacterium to introduce genes from other organisms into a plant. The modified plant then makes the proteins encoded by those genes, but the DNA isn’t incorporated into the plant’s genome, so the effect is short-lived.”Ultimately, those bacteria induced the tobacco plants to produce psilocin and psilocybin, two compounds found in “magic mushrooms”; DMT, which is found in the psychoactive drink ayahuasca; and bufotenin and 5-methoxy-DMT, which are secreted by Colorado river toads. The researchers argue that their method is a much easier way to produce these molecules for medical testing than, say, raising cages full of toads. And it’s doing it across biological kingdoms, creating compounds from fungi, plants, and animals in a single organism.The takeaway: As the article outlines, “the idea of growing drugs through pharmaceutical farming, or ‘pharming,’ certainly isn’t new.” As far back as 2002, we’ve had corn engineered to produce trypsin, a digestive enzyme. But doing it temporarily, without forever altering the plant’s genome, limits the risk of these traits escaping or persisting in the wild.And heck, it makes the infamous “Simpsons” “tomacco” plant look as everyday as a steamed ham. Until next week,WilliamWilliam Herkewitz is a reporter covering global public health for Healthbeat. He is based in Nairobi. Contact William at wherkewitz@healthbeat.org.
18 minutes
A dispute in Mequon tests the limits of local officials’ discretion to reject ballots — and highlights uncertainty about who can overrule them. Wisconsin clerk rejects five absentee ballots over address info, raising legal questions is a post from Wisconsin Watch, a non-profit investigative news site covering Wisconsin since 2009. Please consider making a contribution to support our journalism.
A dispute in Mequon tests the limits of local officials’ discretion to reject ballots — and highlights uncertainty about who can overrule them. Wisconsin clerk rejects five absentee ballots over address info, raising legal questions is a post from Wisconsin Watch, a non-profit investigative news site covering Wisconsin since 2009. Please consider making a contribution to support our journalism.
18 minutes
Records show Austin ISD had a lone bidder step forward to tackle the turnaround of three struggling middle schools as state intervention loomed. The post AISD middle school turnaround contract gets just one bid amid state pressure to improve performance appeared first on Austin Current.
18 minutes
Records show Austin ISD had a lone bidder step forward to tackle the turnaround of three struggling middle schools as state intervention loomed. The post AISD middle school turnaround contract gets just one bid amid state pressure to improve performance appeared first on Austin Current.
18 minutes
The Royals have pitched a $1.9 billion stadium. That’s twice as expensive as Atlanta’s Truist Park and quadruple the cost of Denver’s Coors Field. The post The Royals ‘think big.’ Proposed stadium at Crown Center would be the fourth-most expensive major league ballpark appeared first on The Beacon.
The Royals have pitched a $1.9 billion stadium. That’s twice as expensive as Atlanta’s Truist Park and quadruple the cost of Denver’s Coors Field. The post The Royals ‘think big.’ Proposed stadium at Crown Center would be the fourth-most expensive major league ballpark appeared first on The Beacon.